Search

Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners

Together, these studies reinforce the concept that advanced peptide-based brain shuttle technologies—central to the Gate2Brain platform—are dynamic and adaptable tools for overcoming the challenges of

Under the motto “Global crossroads, local vibes”, the event aims to connect local talent with European and American ecosystems.

Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP

Oryzon secures new patents in Europe and Japan for vafidemstat, extending protection until 2040 for ADHD and autism spectrum disorder.

Oryzon Genomics has launched a clinical trial in the U.S. to evaluate for the first time the combination of its epigenetic inhibitor iadademstat with immunotherapy in patients with metastatic small

Meet our new member Schrödinger. We sponke with María José Aliaga, Associate Account Manager.

The convertible note is a financing instrument that initially functions as a loan and is subsequently converted into a shareholding.

Meet our new member NoctuRNA. We spoke with a Miriam Corredor , CEO.

The report highlights critical vulnerabilities within pharmaceutical supply chains in Europe and proposes substantial investment in strategic projects, procurement policies, and a harmonized and

TECNALIA promotes projects such as INNOPROTEIN, which focus on developing new sources of proteins and functional compounds from agri-food by-products. These advances address sector challenges and the

Premature mortality from cirrhosis in Spain had an economic impact of over €2.4 billion in 2021, according to BCN HEALTH. The study, published in Current Medical Research and Opinion, highlights the